- Home
- QURE vs CNMD Comparison
QURE vs CNMD Comparison
Compare QURE & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QURE | CNMD |
|---|---|---|
| Founded | 1998 | 1970 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2013 | 1995 |
Fundamental Metrics
Financial Performance| Metric | QURE | CNMD |
|---|---|---|
| Price | $26.64 | $36.81 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 5 |
| Target Price | $45.00 | ★ $46.25 |
| AVG Volume (30 Days) | ★ 1.6M | 386.2K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.11% |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ 1.51 |
| Revenue | $13,107,000.00 | ★ $1,374,724,000.00 |
| Revenue This Year | $126.12 | $0.82 |
| Revenue Next Year | $200.43 | $5.48 |
| P/E Ratio | ★ N/A | $25.18 |
| Revenue Growth | N/A | ★ 5.18 |
| 52 Week Low | $8.73 | $33.21 |
| 52 Week High | $71.50 | $60.80 |
Technical Indicators
Market Signals| Indicator | QURE | CNMD |
|---|---|---|
| Relative Strength Index (RSI) | 76.81 | 47.23 |
| Support Level | $22.59 | $35.37 |
| Resistance Level | $28.63 | $46.08 |
| Average True Range (ATR) | 1.80 | 1.88 |
| MACD | 0.89 | 0.01 |
| Stochastic Oscillator | 80.84 | 30.98 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About CNMD CONMED Corporation
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.